-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
The novel approaches to the treatment of eosinophilic granulomatosis with polyangitis
Nobuyuki Miyasaka
Editorial: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Current and emerging therapies for stroke prophylaxis in
atrial fibrillation
Eric TS Lim, Jonathan Yap, Chee Tang Chin
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation